Early Access

10-QPeriod: Q2 FY2016

Elevance Health, Inc. Quarterly Report for Q2 Ended Jun 30, 2016

Filed July 27, 2016For Securities:ELV

Summary

Elevance Health, Inc. (formerly Anthem, Inc.) reported its financial results for the quarter and six months ended June 30, 2016. The company experienced revenue growth driven by higher premium revenue in its Government Business segment and increased administrative fees in its Commercial and Specialty Business segment. However, net income and diluted earnings per share decreased compared to the prior year period. This decline was primarily attributed to higher benefit expenses due to increased medical costs and membership growth, especially in the Medicaid segment, as well as lower net realized gains on financial instruments and costs associated with the pending acquisition of Cigna Corporation. Despite the decrease in profitability, Elevance Health maintained a strong financial position with significant cash and investments. The company continued to manage its operations across its Commercial and Specialty, Government, and Other segments, with the Government Business segment showing robust revenue growth, though its operating gain declined. Investors should note the ongoing strategic initiatives, including the significant pending acquisition of Cigna, which is facing antitrust scrutiny, and the ongoing management of medical cost trends.

Financial Statements
Beta
Revenue$21.46B
SG&A Expenses$2.97B
Operating Income$1.50B
Interest Expense$185.70M
Net Income$780.60M
EPS (Basic)$2.97
EPS (Diluted)$2.91
Shares Outstanding (Basic)263.00M
Shares Outstanding (Diluted)268.20M

Key Highlights

  • 1Total operating revenue increased by 7.7% for both the three and six months ended June 30, 2016, compared to the prior year periods, reaching $21.3 billion and $41.6 billion, respectively.
  • 2Net income decreased by 9.1% to $780.6 million for the three months ended June 30, 2016, and by 14.0% to $1.48 billion for the six months ended June 30, 2016, compared to the prior year.
  • 3Diluted earnings per share (EPS) saw a decline, decreasing by 7.0% to $2.91 for the three months and 10.9% to $5.54 for the six months ended June 30, 2016.
  • 4Benefit expense increased by 10.5% for the three months and 10.3% for the six months ended June 30, 2016, primarily due to higher medical costs and membership growth, particularly in the Medicaid segment.
  • 5The pending acquisition of Cigna Corporation remains a significant event, with the company actively defending against antitrust lawsuits filed by the DOJ and state attorneys general.
  • 6Medical membership increased by 3.2% to 39.8 million members as of June 30, 2016, driven by growth in Medicaid and National Accounts.
  • 7Operating cash flow decreased significantly by $857.2 million for the six months ended June 30, 2016, primarily due to higher claims payments and timing of receipts.

Frequently Asked Questions